Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOcado Regulatory News (OCDO)

Share Price Information for Ocado (OCDO)

Share Price is delayed by 15 minutes
Get Live Data
199.90    -9.30 (-4.45%)
Bid:
202.20
Ask:
202.40
Spread: 0.20 (0.099%)
Market Cap: £1.66b
OCDO Live PriceLast checked at - London Stock Exchange

Intraday Ocado Share Chart

Statement regarding AutoStore

11 Mar 2022 08:01

RNS Number : 4880E
Ocado Group PLC
11 March 2022
 

OCADO GROUP PLC

11 March 2022

 

Ocado Group plc

ITC investigation over: conclusive victory for Ocado

ITC confirms all AutoStore cavity bot patents are invalid

On 10th March, the International Trade Commission, consisting of 5 experienced patent judges, decided in favour of Ocado on all points. Every patent AutoStore asserted in its ITC complaint was found either invalid or not infringed by Ocado's proprietary state of the art technology.

All of the 33 claims that originally constituted AutoStore's complaint to the ITC have now been rejected for a second time, or abandoned by AutoStore. AutoStore's key cavity bot patents, the UK versions of which are the only patents being asserted against Ocado in the High Court case starting next week, were all found to be invalid. A fourth, unrelated, patent was held not to be infringed.

Unusually, the ITC accepted review of the judge's original decision and in the same notice gave its decision on the merits, which further emphasises the strength of these findings.

Ocado continues actively to pursue its claims against AutoStore for infringement of Ocado's IP rights in both the United States and Europe, including its antitrust "Walker Process" claim against AutoStore in East Virginia and its infringement of five Ocado patents in New Hampshire. Ocado anticipates court determinations injuncting AutoStore and awarding Ocado damages for AutoStore's infringement of Ocado's patents.

An Ocado spokesperson said:

"We welcome the ITC's decision, which comprehensively confirms the judge's original findings last December. All 33 of the patent claims asserted against Ocado have now been confirmed for a second time to be either invalid or not infringed, demonstrating again how misguided AutoStore's complaint has been. The ITC investigation is now at its end.

 

We expect further vindication in the High Court in London in the weeks ahead, where AutoStore has already abandoned half of the patents in the case."

 

Contacts

● David Shriver, Director of Communications, Ocado Group plc, on 01707 228 000

● Martin Robinson at Tulchan Communications on 020 7353 4200

 

 

 

Person responsible for arranging the release of this announcement:

 

Neill Abrams

Group General Counsel & Company Secretary

Ocado Group plc

Buildings One & Two

Trident Place

Mosquito Way

Hatfield

Hertfordshire AL10 9UL

Fax: +44 (0)1707 227 997

email: company.secretary@ocado.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFIFEDVAILLIF
Date   Source Headline
24th Mar 202511:46 amRNSHolding(s) in Company
24th Mar 202511:18 amRNSHolding(s) in Company
20th Mar 20254:29 pmRNSDirector/PDMR Shareholding
13th Mar 20251:06 pmRNSDirector/PDMR Shareholding
12th Mar 20259:28 amRNSAdditional Listing
6th Mar 20253:31 pmRNSDirector/PDMR Shareholding
5th Mar 20256:07 pmRNSAnnual Financial Report and AGM Notice
3rd Mar 20255:11 pmRNSTotal Voting Rights
27th Feb 20257:00 amRNSFinal Results
20th Feb 202511:14 amRNSDirector/PDMR Shareholding
3rd Feb 20251:51 pmRNSTotal Voting Rights
28th Jan 20259:02 amRNSBlock listing Interim Review
16th Jan 202512:58 pmRNSHolding(s) in Company
16th Jan 202510:13 amRNSDirector/PDMR Shareholding
14th Jan 20257:00 amRNSTrading Statement
2nd Jan 202511:06 amRNSTotal Voting Rights
17th Dec 20241:26 pmRNSDirector/PDMR Shareholding
16th Dec 20244:35 pmRNSAdditional Listing
2nd Dec 202411:42 amRNSTotal Voting Rights
28th Nov 20247:00 amRNSUpdate on shared UK CFCs
15th Nov 20245:02 pmRNSDirector/PDMR Shareholding
1st Nov 202412:02 pmRNSTotal Voting Rights
31st Oct 20247:00 amRNSUpdate on Chair Appointment
22nd Oct 20245:18 pmRNSDirector/PDMR Shareholding
16th Oct 202411:19 amRNSDirector/PDMR Shareholding
1st Oct 20242:13 pmRNSTotal Voting Rights
19th Sep 20247:00 amRNSTrading Statement
16th Sep 20244:21 pmRNSDirector/PDMR Shareholding
2nd Sep 202411:56 amRNSTotal Voting Rights
27th Aug 20247:00 amRNSLaunch of Coles CFCs in Australia
21st Aug 20242:16 pmRNSHolding(s) in Company
15th Aug 20244:00 pmRNSDirector/PDMR Shareholding
12th Aug 20247:00 amRNSAdditional Listing
9th Aug 20247:00 amRNSBlock listing Interim Review
7th Aug 20249:09 amRNSResult of Tender Offer
5th Aug 20247:00 amRNSMaximum Spend Amount related to Tender Offer
1st Aug 20246:22 pmRNSUpsizing and pricing of High Yield Bond Offering
1st Aug 202411:21 amRNSTotal Voting Rights
30th Jul 20247:00 amRNSPricing of £250 million Convertible Bond Offering
29th Jul 20244:36 pmRNSProposed Convertible Bond Offering
29th Jul 20244:36 pmRNSProposed High Yield Bond Offering
29th Jul 20244:36 pmRNSTender Offer
24th Jul 20246:22 pmRNSDirectors' Dealings
22nd Jul 20247:00 amRNSKroger roll out of new technology enhancements
16th Jul 20244:01 pmRNSDirector/PDMR Shareholding
16th Jul 20247:00 amRNSHalf-year Report
8th Jul 20247:00 amRNSAeon Update
1st Jul 20245:08 pmRNSTotal Voting Rights
20th Jun 202411:37 amRNSUpdate on Sobeys Partnership
18th Jun 20244:32 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.